Réf. :HematoStat.net ; 1 (1) : V7 Herbaux C, Kornauth C, Poulain S, Chong SJF, Collins MC, Valentin R, Hackett L, Tournilhac O, Lemonnier F, Dupuis J, Daniel A, Tomowiak […]

Réf. :HematoStat.net ; 1 (1) : V8 Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia. Doi 10.1038/s41467-021-22874-x  

Réf. :HematoStat.net ; 1 (1) : V5 FLT3 mutated acute myeloid leukemia: 2021 treatment algorithm. Doi 10.1038/s41408-021-00495-3  

Réf. :HematoStat.net ; 1 (1) : V4 Griggs JJ, Bohlke K, Balaban EP, Dignam JJ, Hall ET, Harvey RD, Hecht DP, Klute KA, Morrison VA, Pini TM, Rosner GL, Runowicz […]

Réf. :HematoStat.net ; 1 (1) : V3 Vitale C, Salvetti C, Griggio V, Porrazzo M, Schiattone L, Zamprogna G, Visentin A, Vassallo F, Cassin R, Rigolin GM, Murru R, Laurenti […]

Réf. :HematoStat.net ; 1 (1) : V2 Venetoclax Combined With FLAG-IDA Induction and Consolidation in Newly Diagnosed and Relapsed or Refractory Acute Myeloid Leukemia. Doi 10.1200/JCO.20.03736.

Réf. :HematoStat.net ; 1 (1) : V1 Cherng HJ, Jammal N, Paul S, Wang X, Sasaki K, Thompson P, Burger J, Ferrajoli A, Estrov Z, O’Brien S, Keating M, Wierda […]